Phase 3 Chronic Heart Failure Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

Iron DeficienciesChronic Heart Failure

Pharmacosmos A/S1,900 enrolled1 locationNCT06929806

Recruiting

Phase 2Phase 3

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

ObesityWeight LossHeart Failure With Reduced Ejection Fraction+1 more

Jens D Hove, MD,PHD100 enrolled1 locationNCT06423599

Recruiting

Phase 3

S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction

Chronic Heart Failure With Reduced Ejection Fraction

Shenzhen People's Hospital5 enrolled1 locationNCT05553886